Ipca Laboratories has increased its Research and Development (R&D) expenditure to Rs 100.74 crore in FY’13 as compared to Rs 77.96 crore in the previous year. The company has R&D centres at Mumbai, Ratlam, Athal and Indore. The company has set up a new centre at its Mumbai facility for expanding its formulations R&D activities. It is also in the process of setting up a new research centre at Kandivli in Mumbai for bio-tech research & development activities.
Further, the company is also in the process of setting-up a new R&D Centre at Vadodara in Gujarat.
IPCA Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.
